Please see below for a list of search results.
Schedule 1 of the Human Tissue Act 2004 (the Act) sets out ‘performance assessment’ as a ‘scheduled purpose’.
An HTA licence is required if the human cellular material (‘relevant material’) to be stored for performance assessment has been removed from the deceased.
Role of Designated Individual
Designated Individuals have a key role to play in implementing the requirements of the HT Act.
Our Codes of Practice and Standards provide practical guidance to professionals carrying out activities within the scope of the HTA’s remit.
This position statement outlines guidance provided on consent for post-mortem examination and tissue retention.
The GMC provides guidance setting out good practice principles for doctors involved in research.
Under the Human Tissue Act 2004, the HTA is required to license the storage of relevant material for ‘research in connection with disorders, or the functioning, of the human body’.
Download these standards as a PDF.Consent standards
C1 Consent is obtained in accordance with the requirements of the Human Tissue Act 2004 (HT Act) and as set out in the code of practice
The Human Tissue Act 2004 requires that the removal of tissue from the deceased for research within the scope of the Act must always be licensed, on specified premises, and that specific minimum requirements are met.